ANGUS Chemical Company Names Dave Neuberger as Chief Executive Officer
BUFFALO GROVE, Ill.–(BUSINESS WIRE)–ANGUS Chemical Company ("ANGUS" or the “Company”), a leading global
manufacturer and marketer of specialty and fine chemicals, today
announced the appointment of Dave Neuberger as Chief Executive Officer
(CEO), effective immediately. Mr. Neuberger succeeds Mark Henning, who
will step down as CEO.
Mr. Neuberger is an industry veteran with 20 years of experience. He has
held a variety of leadership roles with leading chemicals companies. He
joins ANGUS after a decade with Ashland Inc., a global specialty
chemicals company, where he most recently served as Group Vice President
of the company’s Pharmaceutical, Agriculture and Nutrition Specialties
business. In that role, Mr. Neuberger oversaw Ashland’s most profitable
P&L, and he managed a pipeline of new product introductions. During his
time at Ashland, Mr. Neuberger also led the company’s North American
Industrial Specialties business, including all commercial, technical
service and supply chain functions.
Robert Kirby, Chairman of the ANGUS Board of Directors, said: “Dave’s
track record of building, growing and managing specialty chemicals
businesses makes him the ideal person to lead ANGUS into its next
chapter. Dave has decades of diverse leadership experience across the
chemicals industry, as well as a strong, results-driven approach that
will immediately create value and position ANGUS for future growth
opportunities. We appreciate Mark’s decades of service to ANGUS, and are
particularly grateful for his stewardship of the Company during the
carve-out from the Dow Chemical Company. We look forward to working with
Dave as we continue to grow the business.”
Mr. Neuberger said: “It is a privilege to join a company of ANGUS’
caliber and work alongside the talented ANGUS management team. ANGUS has
an impressive customer base across a variety of end markets, and I am
excited to support the Company’s mission to empower customers through
science and technology and help steer ANGUS into its next phase.”
Rajeev Amara, a Managing Director at Golden Gate Capital and ANGUS Board
member, added, “We are pleased to welcome Dave to the ANGUS team. This
is an exciting moment in the Company’s history: ANGUS is the only
vertically-integrated global provider of many of the foundational
chemicals used in the production of next-generation medicine, including
biologics and cell therapy, and we are confident that Dave’s experience
and expertise in those sectors will significantly accelerate the
Company’s growth.”
Prior to Ashland, Mr. Neuberger spent nearly a decade at W.R. Grace,
where he most recently served as Manager of New Business Development at
the company’s specialty chemicals and materials division. He earned a
MBA in Finance from the University of Pennsylvania, where he was a
Palmer Scholar, and a BS in Chemical Engineering from Johns Hopkins
University.
About ANGUS Chemical Company
ANGUS Chemical Company, a portfolio company of Golden Gate Capital, is a
specialty and fine chemical company dedicated to the development of
novel chemistries that help customers deliver enhanced product and
process performance. ANGUS is committed to constantly improving products
and services by mastering science and technology. The company innovates
through its unique nitroalkane chemistry, which harbors the reactivity
to create complex molecules for use in a wide variety of applications.
The innate characteristics of this chemistry, backed by unmatched
application expertise and five regional Customer Applications Centers,
enable the formulation of multifunctional additives that improve
performance, and reduce reaction steps and synthesis costs.
Follow ANGUS on Facebook, Twitter,
and LinkedIn.
Contacts
ANGUS Chemical Company
Scott C. Johnson, 847-808-3769
[email protected]
